Article
Circulating Tumor DNA in Breast Cancer: Current and Future Applications.
Clinical breast cancer - 1 Oct 2023
Medford Arielle J, Denault Elyssa N, Moy Beverly, Parsons Heather A, Bardia Aditya
Abstract excerpt
The assessment of plasma for circulating tumor DNA (ctDNA) via liquid biopsy has revolutionized our understanding of breast cancer pathogenesis and evolution. Historically, genotyping evaluation of breast cancer required invasive tissue biopsy, limiting potential for serial evaluation over the treatment course of advanced breast cancer, and not allowing for assessment for residual disease in early breast cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
